Zen Technologies Limited (ZENTEC)

Capital Goods · Aerospace & Defense · NSE · Updated 4 August 2026
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
₹1,656.4 ↑ 10.67% (1Y)

🎯 Key Takeaways

  • Zen Technologies Limited is navigating a strategic inflection point marked by governance updates and financial volatility. The company has recently strengthened its board with new independent oversight while grappling with a sharp revenue contraction and margin compression in its core aerospace and defense segment.
  • Revenue declined 37.1% QoQ to ₹152 in Q3FY25.
  • ⚠️ Governance uncertainty due to pending shareholder approval of key director appointments, which could impact board stability and decision-making.
Market Cap
₹14,039
P/E Ratio
62.0
Div Yield
0.00%
Promoter
0.0%

📖 The Story

Zen Technologies Limited is navigating a strategic inflection point marked by governance updates and financial volatility. The company has recently strengthened its board with new independent oversight while grappling with a sharp revenue contraction and margin compression in its core aerospace and defense segment. These developments signal a transitional phase where leadership changes and capital allocation decisions are being tested against evolving market dynamics.

📰 What's Happening

In the latest board meeting on July 25, 2026, Zen Technologies appointed Mr. Jasthi Krishna Kishore as an Independent Director and reappointed Mrs. Shilpa Choudari as Whole-Time Director, both pending shareholder approval. The board also approved unaudited Q1 FY2026 financials showing total income of ₹16,079.48 lakhs and net profit of ₹3,446.10 lakhs. Additionally, the company granted 14,100 employee stock options under its 2021 ESOP scheme at ₹250 per option. Management extended QIP fund utilization until August 22, 2028, but disclosed significant deviations in capital deployment across strategic categories.

Source: Stock Announcements

📊 Quarterly Results (₹ Cr)

MetricQ4FY23Q1FY24Q2FY24Q3FY24Q4FY24Q1FY25Q2FY25Q3FY25
Revenue9613267100141255242152
Operating Profit35722447551148866
OPM %36.7%52.0%28.5%42.7%35.6%43.7%33.1%29.0%
Net Profit2348143038796343
EPS₹2.55₹5.81₹1.83₹3.67₹4.19₹9.19₹7.26₹4.42

The company's quarterly revenue has declined sharply from a peak of ₹255 crore in Q1 FY25 to ₹152 crore in Q3 FY25, reflecting weakening demand or project delays in its aerospace and defense segment. Operating margins have also compressed from 52% in Q1 FY24 to 29% in Q3 FY25, indicating rising cost pressures or pricing headwinds. Despite this, net profit and EPS remain volatile, with Q1 FY25 reporting ₹79 crore net profit and ₹9.19 EPS, down from ₹48 crore and ₹5.81 EPS in the prior year's Q4. The financial trend suggests operational challenges that management has not yet stabilized through cost optimization or revenue diversification.

🔮 Management Outlook & What's Next

Management has not provided explicit forward guidance on revenue recovery or margin improvement in the latest filings. However, the extension of QIP fund utilization until August 2028 indicates continued access to capital markets for strategic needs. The board appointments are framed as enhancements to governance rather than catalysts for operational change, and no specific targets for performance improvement or market expansion were disclosed in the recent regulatory submissions.

Extracted from official company announcements. Not StockFin.ai's opinion.

⚖️ Peer Comparison — Aerospace & Defense

Company MCap (₹ Cr) P/E ROCE ROE D/E
Bharat Electronics Limited 3.10 L Cr 62.0
Hindustan Aeronautics Limited 2.93 L Cr 33.7
Bharat Dynamics Limited 48,584 83.8
Garden Reach Shipbuilders & Engineers Limited 30,768 41.1
Data Patterns (India) Limited 21,702 80.0
Zen Technologies Limited 14,039 62.0
Aequs Limited 13,582
Apollo Micro Systems Limited 10,524 111.6 18.2% 14.7% 0.54
Astra Microwave Products Limited 10,507 78.2
AXISCADES Technologies Limited 8,751 163.2

🔗 Peer Stock Analyses

⚠️ Risk Factors

1. Governance uncertainty due to pending shareholder approval of key director appointments, which could impact board stability and decision-making. 2. Persistent revenue and margin decline in core segments, with no clear recovery pathway disclosed. 3. Underutilization of QIP funds across strategic categories, raising concerns about execution capability or project pipeline readiness. 4. Exposure to exceptional losses from damaged inventory and treasury share transactions, which can distort profitability and investor sentiment.

📋 Recent Filings

🧠 Analyst's Read

Investors should monitor the outcome of shareholder votes on director appointments and the company's ability to deploy capital effectively toward high-return initiatives. The next earnings release will be critical to assess whether the downward trend in revenue and margins stabilizes or accelerates under new board oversight.

Based on filing content and financial data. Not a recommendation.

Read the full analysis

Quarterly trends, balance sheet, cash flow, peer comparison, and AI insights — sign up free to unlock.

Sign Up Free — Unlock Full Analysis

2 free AI queries per day.

Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-08-04.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when ZENTEC files new disclosures

Track ZENTEC filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ZENTEC — Free

Free account · 2 AI queries/day